Please note, this OEL/ADE monograph applies to dextran 40 and 70 (CAS RN 9004-54-0) and dextran sodium sulfate (CAS RN 9011-18-1). Dextran is a synthetic colloid consisting of mixture of glucose polymers derived from the action of Leuconostoc mesenteroides on sucrose and is currently available in 10% dextran 40 (40 kDa) and 6% dextran 70 (70 kDa). Dextrans have high water-binding capacity; for example, 1 g of dextran 40 retains 30 mL of water, while 1 g dextran 70 retains 20 to 25 mL of water (3). Dextrans are used therapeutically as plasma volume expanders and anticoagulants. They are also commonly used in biological experimentation and in industry for a wide variety of purposes.
Affygility Solutions has an occupational exposure limit (OEL) and control band assignment for this active pharmaceutical ingredient (API). This monograph also contains the acceptable daily exposure (ADE) value.
OEL Fastrac monographs are a cost-effective and convenient way to meet the requirements for PDEs (ADEs) contained in the EMA Guideline on setting health based exposure limits for use in risk identification in the manufacture of different medicinal products in shared facilities (EMA/CHMP/CVMP/SWP/169430/2012), as well as PIC/S and ANVISA requirements, and to obtain the following information:
To order an OEL/ADE monograph for Dextran, just click the ADD TO CART button.
If you're wondering about HBEL, we have something for you.
Not the compound you were looking for? You can search the OEL Fastrac catalog to find more available compounds.
Affygility Solutions’ OEL Fastrac service is an user-friendly system that enables us to make confident decisions and focus on moving the compound safely through our facility. We can quickly access the database to determine if a new drug is within the OEL Fastrac library, and if so, immediately download a detailed OEL banding report. The OEL Fastrac system has been a helpful tool in our overall EH&S program.